United States · Bill · HR
H.R. 512 (114th)
DISARM Act of 2015
Introduced
22 January 2015
Last action
5 February 2015 · Referred
Status
Referred to the Subcommittee on Health.
Sponsors
Rep. Roskam, Peter J. [R-IL-6], Rep. Davis, Danny K. [D-IL-7], Rep. Lieu, Ted [D-CA-36], Rep. Kelly, Mike [R-PA-16], Rep. Buchanan, Vern [R-FL-16], Rep. Payne, Donald M., Jr. [D-NJ-10], Rep. Ellmers, Renee L. [R-NC-2], Rep. Pascrell, Bill, Jr. [D-NJ-9], Rep. Boustany, Charles W., Jr. [R-LA-3], Rep. Sánchez, Linda T. [D-CA-38], Rep. Bucshon, Larry [R-IN-8], Rep. Meehan, Patrick [R-PA-7], Rep. Sensenbrenner, F. James, Jr. [R-WI-5]
Subjects
Healthcare, Taxation
Source updated
12 August 2025
Summary
Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2015 or the DISARM Act of 2015 Amends title XVIII (Medicare) of the Social Security Act to direct the Secretary of Health and Human Services to: (1) recognize the costs of DISARM antimicrobial drugs under the Medicare payment system for the inpatient services of subsection (d) hospitals, (2) provide for additional payment with respect to discharges involving such drugs, (3) publish in the Federal Register a list of the DISARM antimicrobial drugs, and (4) make a proportional adjustment in standardized payment amounts to assure that the requirements of this Act do not result in aggregate payments greater or less than those that would otherwise be made for a fiscal year. (Generally, a subsection [d] hospital is an acute care hospital, particularly one that receives payments under Medicare's inpatient prospective payment system [IPPS] when providing covered inpatient services to eligible beneficiaries.) Defines a "DISARM antimicrobial drug" as one approved or licensed by the Food and Drug Administration on or after January 1, 2015, which, among other things, is intended to treat an infection: caused by, or likely to be caused by, a qualifying pathogen; associated with high rates of mortality or significant patient morbidity; and for which there is an unmet medical need. Requires that the mechanism established by the Secretary to recognize the costs of new medical services and technologies that are not DISARM antimicrobial drugs under the Medicare payment system is applicable to new medical services or technology if the service or technology is not a DISARM antimicrobial drug. Directs the Comptroller General to study the barriers that prevent the development of DISARM antimicrobial drugs and develop recommendations for actions to be taken in order to overcome those barriers.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
22 January 2015
Introduced
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: IntroReferral
22 January 2015
Introduced
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: IntroReferral
22 January 2015
Introduced
Introduced in House
Source: IntroReferral
22 January 2015
Introduced
Introduced in House
Source: IntroReferral
23 January 2015
Referred
Referred to the Subcommittee on Health.
Source: Committee
5 February 2015
Referred
Referred to the Subcommittee on Health.
Source: Committee
Votes
No vote records are attached yet.
Versions
- Introduced in House · 22 January 2015 · Download file
Documents
3 official files
Introduced in House (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (text)
Introduced in House · EN · 22 January 2015
Introduced in House (PDF)
Introduced in House · EN · 22 January 2015
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 22 January 2015
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Rep. Roskam, Peter J. [R-IL-6] · R · Sponsor
- Rep. Davis, Danny K. [D-IL-7] · D · Sponsor
- Rep. Lieu, Ted [D-CA-36] · D · Cosponsor
- Rep. Kelly, Mike [R-PA-16] · R · Cosponsor
- Rep. Buchanan, Vern [R-FL-16] · R · Cosponsor
- Rep. Payne, Donald M., Jr. [D-NJ-10] · D · Cosponsor
- Rep. Ellmers, Renee L. [R-NC-2] · R · Cosponsor
- Rep. Pascrell, Bill, Jr. [D-NJ-9] · D · Cosponsor
- Rep. Boustany, Charles W., Jr. [R-LA-3] · R · Cosponsor
- Rep. Sánchez, Linda T. [D-CA-38] · D · Cosponsor
- Rep. Bucshon, Larry [R-IN-8] · R · Cosponsor
- Rep. Meehan, Patrick [R-PA-7] · R · Cosponsor
- Rep. Sensenbrenner, F. James, Jr. [R-WI-5] · R · Cosponsor
- · hswm00 · Standing
- · hsif00 · Standing
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/114th-congress/house-bill/512
- Open data entity: https://api.congress.gov/v3/bill/114/hr/512
- us · 114-hr-512 · source updated 12 August 2025